{
    "2018-05-23": [
        [
            {
                "time": "2018-05-23",
                "original_text": "After Hours Most Active for May 23, 2018: GE, F, BAC, MSFT, ABBV, CFG, INTC, CSCO, DCUD, MDLZ, AAPL, AMAT",
                "features": {
                    "keywords": [
                        "Most Active",
                        "GE",
                        "F",
                        "BAC",
                        "MSFT",
                        "ABBV",
                        "CFG",
                        "INTC",
                        "CSCO",
                        "AAPL"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "technology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-23",
                "original_text": "Analysts Expect 10% Gains Ahead For The Holdings of FTHI",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Expect",
                        "Gains",
                        "FTHI"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "financial services"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-23",
                "original_text": "Eli Lilly Gets FDA Approval for Taltz in Genital Psoriasis",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "FDA Approval",
                        "Taltz",
                        "Genital Psoriasis"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-23",
                "original_text": "Better Buy: AbbVie Inc. vs. Pfizer Inc.",
                "features": {
                    "keywords": [
                        "Better Buy",
                        "AbbVie Inc.",
                        "Pfizer Inc."
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}